HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pierre Quartier Selected Research

Juvenile Arthritis (Juvenile Idiopathic Arthritis)

1/2022Anakinra in Patients With Systemic Juvenile Idiopathic Arthritis: Long-term Safety From the Pharmachild Registry.
10/2021Clinical effectiveness and safety of baricitinib for the treatment of juvenile idiopathic arthritis-associated uveitis or chronic anterior antinuclear antibody-positive uveitis: study protocol for an open-label, adalimumab active-controlled phase 3 clinical trial (JUVE-BRIGHT).
9/2021Immunomodulatory treatment and surgical management of idiopathic uveitis and juvenile idiopathic arthritis-associated uveitis in children: a French survey practice.
6/2021Juvenile Idiopathic Arthritis-Associated Chronic Uveitis: Recent Therapeutic Approaches.
3/2021Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis.
1/2021Tapering Canakinumab Monotherapy in Patients With Systemic Juvenile Idiopathic Arthritis in Clinical Remission: Results From a Phase IIIb/IV Open-Label, Randomized Study.
1/2021Absence of Association Between Abatacept Exposure and Initial Infection in Patients With Juvenile Idiopathic Arthritis.
12/2020Efficacy and Safety of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis With and Without Fever at Baseline: Results From an Open-Label, Active-Treatment Extension Study.
10/2020Safety and Effectiveness of Adalimumab in Patients With Polyarticular Course of Juvenile Idiopathic Arthritis: STRIVE Registry Seven-Year Interim Results.
2/2020Maintenance of antibody response to diphtheria/tetanus vaccine in patients aged 2-5 years with polyarticular-course juvenile idiopathic arthritis receiving subcutaneous abatacept.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pierre Quartier Research Topics

Disease

43Juvenile Arthritis (Juvenile Idiopathic Arthritis)
01/2022 - 10/2002
13Inflammation (Inflammations)
02/2019 - 06/2007
12Uveitis
10/2021 - 12/2010
11Infections
01/2021 - 03/2002
9Dermatomyositis (Dermatopolymyositis)
11/2022 - 11/2010
9Fever (Fevers)
12/2020 - 06/2007
8Myositis (Idiopathic Inflammatory Myopathies)
11/2022 - 03/2012
7Arthritis (Polyarthritis)
10/2021 - 04/2003
6Cryopyrin-Associated Periodic Syndromes
11/2022 - 07/2002
5Mevalonate Kinase Deficiency
09/2020 - 06/2007
4Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2019 - 08/2010
3Macrophage Activation Syndrome
03/2022 - 12/2012
3Anterior Uveitis
06/2021 - 01/2018
3Rheumatic Diseases (Rheumatism)
01/2020 - 01/2007
3Familial Mediterranean Fever (Periodic Disease)
01/2018 - 10/2011
3Arthralgia (Joint Pain)
01/2017 - 01/2009
3Vasculitis (Vasculitides)
07/2015 - 10/2011
3Body Weight (Weight, Body)
06/2015 - 02/2012
3Pain (Aches)
07/2012 - 01/2009
2Proteinuria
11/2022 - 03/2012
2Neoplasms (Cancer)
01/2022 - 01/2019
2Polyarteritis Nodosa (Periarteritis Nodosa)
12/2021 - 07/2015
2Calcinosis
07/2019 - 04/2010
2Necrosis
01/2019 - 08/2008
2Glomerulonephritis
01/2019 - 03/2012
2Adult-Onset Still's Disease
07/2018 - 01/2011
2Muscle Weakness
01/2018 - 08/2002
2Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
05/2017 - 02/2003
2Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
04/2015 - 01/2014
2Chronic Granulomatous Disease
02/2015 - 03/2002
1Graft vs Host Disease (Graft-Versus-Host Disease)
03/2021
1Myocarditis (Carditis)
06/2020
1Critical Illness (Critically Ill)
06/2020
1Hypotension (Low Blood Pressure)
06/2020
1Shock
06/2020
1Tetanus
02/2020
1Diphtheria
02/2020
1Interstitial Lung Diseases (Interstitial Lung Disease)
01/2020
1Familial Hyperphosphatemic Tumoral Calcinosis
07/2019
1Disease Progression
02/2019

Drug/Important Bio-Agent (IBA)

13Methotrexate (Mexate)FDA LinkGeneric
11/2022 - 08/2002
10canakinumabFDA Link
01/2021 - 06/2009
8Interleukin-1 (Interleukin 1)IBA
11/2022 - 06/2009
8Adrenal Cortex Hormones (Corticosteroids)IBA
11/2022 - 08/2002
8Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2021 - 06/2007
7Abatacept (Orencia)FDA Link
01/2021 - 08/2008
6Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
01/2022 - 01/2010
6CytokinesIBA
10/2021 - 04/2012
6Biological ProductsIBA
01/2019 - 09/2011
5Antinuclear AntibodiesIBA
10/2021 - 02/2014
5Adalimumab (Humira)FDA Link
10/2021 - 01/2016
5GlucocorticoidsIBA
01/2021 - 07/2007
5InterferonsIBA
01/2020 - 08/2015
5SteroidsIBA
05/2019 - 10/2005
4AutoantibodiesIBA
11/2022 - 01/2018
4C-Reactive ProteinIBA
10/2020 - 01/2009
4ColchicineFDA LinkGeneric
09/2020 - 10/2011
4AntibodiesIBA
01/2019 - 05/2010
4Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
07/2015 - 03/2012
4Rituximab (Mabthera)FDA Link
07/2011 - 02/2003
3Janus Kinase InhibitorsIBA
03/2022 - 10/2021
3tocilizumab (atlizumab)FDA Link
12/2021 - 06/2015
3Cyclosporine (Ciclosporin)FDA LinkGeneric
03/2021 - 08/2002
3Antirheumatic Agents (DMARD)IBA
02/2020 - 08/2008
3Etanercept (Enbrel)FDA Link
01/2019 - 04/2003
3Immunosuppressive Agents (Immunosuppressants)IBA
06/2017 - 06/2007
3Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
09/2011 - 01/2010
2Interleukin-6 (Interleukin 6)IBA
03/2022 - 04/2012
2Janus KinasesIBA
03/2022 - 10/2021
2Monoclonal AntibodiesIBA
06/2021 - 12/2010
2Mycophenolic Acid (Cellcept)FDA LinkGeneric
03/2021 - 03/2012
2Biomarkers (Surrogate Marker)IBA
01/2020 - 02/2019
2Phosphates (Orthophosphate)IBA
07/2019 - 04/2010
2Pharmaceutical PreparationsIBA
01/2019 - 02/2016
2Proteins (Proteins, Gene)FDA Link
01/2018 - 01/2017
2LipopolysaccharidesIBA
01/2018 - 01/2016
2Rheumatoid FactorIBA
02/2014 - 06/2007
2Creatine Kinase (Creatine Phosphokinase)IBA
05/2013 - 08/2002
22-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA
05/2013 - 03/2012
2ametantrone (HAQ)IBA
07/2012 - 10/2002
2NucleotidesIBA
04/2012 - 07/2002
1AA amyloidosisIBA
11/2022
1Thalidomide (Thalomid)FDA Link
03/2022
1Interferon-gamma (Interferon, gamma)IBA
03/2022
1InterleukinsIBA
03/2022
1baricitinibIBA
10/2021
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
03/2021
1TroponinIBA
06/2020
1VaccinesIBA
02/2020
1Diphtheria-Tetanus VaccineIBA
02/2020

Therapy/Procedure

17Therapeutics
03/2022 - 08/2002
5Biological Therapy
05/2019 - 12/2010
3Hematopoietic Stem Cell Transplantation
03/2022 - 04/2013
2Slit Lamp
06/2021 - 01/2018
2Bone Marrow Transplantation (Transplantation, Bone Marrow)
03/2021 - 06/2007
2Lasers (Laser)
01/2018 - 11/2011
1Operative Surgical Procedures
09/2021
1Drug Tapering
12/2020
1Central Venous Catheters
10/2019
1Aftercare (After-Treatment)
01/2019